Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Triple-Scan Protocol to Assess Passivity

NCT: NCT07644689 · COMPLETED

NCT IDNCT07644689
StatusCOMPLETED
Start Date2023-04-23
Completion2025-02-15
SponsorMansoura University (OTHER)
First posted
Last updated

Brief Summary

Quantification and visualization the internal and marginal gaps by newer digital methods, such as the triple-scan protocol described by Borga Dönmez et al. (2024), employing 3D analysis software, offering a more objective and reproducible assessment.

Frequently Asked Questions

What is Triple-Scan Protocol to Assess Passivity?

Triple-Scan Protocol to Assess Passivity is a clinical trial registered under NCT07644689. Current status: COMPLETED.

What is the status of NCT07644689?

The current status of NCT07644689 (Triple-Scan Protocol to Assess Passivity) is: COMPLETED.

When did Triple-Scan Protocol to Assess Passivity start?

Triple-Scan Protocol to Assess Passivity started on 2023-04-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.